Gevorg Tamamyan. In this episode, we have the honor of featuring Fadlo R. Khuri, who is the 16th and current president of the American University of Beirut. Khuri was also a professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine and was the editor-in-chief of the medical journal Cancer.
In the interview, Fadlo R. Khuri explores his background, discussing his family, upbringing, and cultural heritage. He shares about the individuals who had an influence on his career, emphasizing the role of mentors in his journey to success. Additionally, Khuri reflects on the future of oncology, offering insights into upcoming developments and the potential impact on cancer treatment. Fadlo R. Khuri is the president of the American University of Beirut. Goizueta Distinguished Chair for Cancer Research.
Specifically, his laboratory group investigates the mechanisms of action of signal transduction inhibitors in these types of cancers, focusing on selective activation of certain signaling networks.
Khuri has authored over peer-reviewed articles and serves as the editor-in-chief of Cancer. The host, Dr. Khuri moved from US to Lebanon? Khuris initiatives Prof. Khuri describes him in one sentence Thing that makes Prof. Khuri proud of What is the leadership? Gevorg Tamamyan : Hello everyone. Welcome back to OncoDaily. We are at the OncoInfluencers and today we are honored to host a professor Fadlo Khuri from Lebanon, the 16th president of the American University of Beirut.
Thank you very much, Doctor Khoury, for having time for us. So, Dr. Fadlo Khoury is the 16th president of the American University of Beirut, was elected in March and assumed office in September Doctor Khoury was also the executive associate dean for research of the Emory University School of Medicine and the editor-in-chief of Cancer.
